Related references
Note: Only part of the references are listed.Circulating MicroRNAs as Biomarkers of Colorectal Cancer: Results From a Genome-Wide Profiling and Validation Study
Maria Dolores Giraldez et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review
Haggi Mazeh et al.
JOURNAL OF CANCER (2013)
Complications Following Colonoscopy With Anesthesia Assistance A Population-Based Analysis
Gregory S. Cooper et al.
JAMA INTERNAL MEDICINE (2013)
The influence of species interactions on geographic range change under climate change
Jessica J. Hellmann et al.
YEAR IN ECOLOGY AND CONSERVATION BIOLOGY (2012)
MicroRNA and colorectal cancer
Helene Corte et al.
DIGESTIVE AND LIVER DISEASE (2012)
Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer
Ziad Kanaan et al.
HUMAN MUTATION (2012)
The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors
Bing Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Ke Zen et al.
MEDICINAL RESEARCH REVIEWS (2012)
The flexible sigmoidoscopie can save lives
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer
Qifeng Wang et al.
PLOS ONE (2012)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Douglas G. Altman et al.
PLOS MEDICINE (2012)
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
Robert E. Schoen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Circulating microRNAs: Association with disease and potential use as biomarkers
Glen Reid et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts (vol 282, pg 12363, 2007)
Jiening Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Characterization of extracellular circulating microRNA
Andrey Turchinovich et al.
NUCLEIC ACIDS RESEARCH (2011)
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
Hanyin Cheng et al.
PLOS ONE (2011)
MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
Lena M. Wulfken et al.
PLOS ONE (2011)
Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison With Qualitative Tests
Ulrike Haug et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening
Alexander Link et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening
Yoshikatsu Koga et al.
CANCER PREVENTION RESEARCH (2010)
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Zhaohui Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
Xing-xiang Pu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Application of housekeeping npcRNAs for quantitative expression analysis of human transcriptome by real-time PCR
Chenna R. Galiveti et al.
RNA (2010)
Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection
Sabrina Hundt et al.
ANNALS OF INTERNAL MEDICINE (2009)
A Multicenter Study of Prevalence and Risk Factors for Aberrant Crypt Foci
Matthew G. Mutch et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
E. K. O. Ng et al.
GUT (2009)
Molecular markers and targets for colorectal cancer prevention
Naveena B. Janakiram et al.
ACTA PHARMACOLOGICA SINICA (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The global burden of urinary bladder cancer
D. Maxwell Parkin
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2008)
Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies
Hermann Brenner et al.
GUT (2007)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Sample size for FDR-control in microarray data analysis
SH Jung
BIOINFORMATICS (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging
JB O'Connell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Colorectal cancer screening - Scientific review
JME Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The colorectal adenoma-carcinoma sequence
A Leslie et al.
BRITISH JOURNAL OF SURGERY (2002)
Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence
F Citarda et al.
GUT (2001)
Share Paper
